Decreased myeloid dendritic cells indicate a poor prognosis in patients with severe fever with thrombocytopenia syndrome

International Journal of Infectious Diseases

Volumn 54, Issue , 2017, Pages 113-120

  Zhang, Wenjing ^a   Li, Mengmeng ^a   Xiong, Shue ^a   Wang, Hua ^a   Xiong, Yan ^a   Li, Mingyue ^a   Lu, Mengji ^b   Yang, Dongliang ^a   Peng, Cheng ^a   Zheng, Xin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acute phase; Dendritic cell; Mortality; Prognosis; Severe fever with thrombocytopenia syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; B7 ANTIGEN; CD86 ANTIGEN; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 10; INTERLEUKIN 6; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BUNYAVIRUS INFECTION; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLOW CYTOMETRY; FREQUENCY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; SYNDROME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS LOAD; BLOOD; CELL COUNT; CYTOLOGY; DENDRITIC CELL; IMMUNOLOGY; MIDDLE AGED; PHLEBOVIRUS; PHYSIOLOGY; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; DENDRITIC CELLS; FEMALE; FEVER; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PHLEBOVIRUS; PROGNOSIS; ROC CURVE; THROMBOCYTOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85007072422     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.11.418     Document Type: Article

References (33)

1. 1 Weng, Y., Chen, N., Han, Y., Xing, Y., Li, J., Clinical and laboratory characteristics of severe fever with thrombocytopenia syndrome in Chinese patients. Braz J Infect Dis 18 (2014), 88–91.
2. 2 Kim, K.H., Yi, J., Kim, G., Choi, S.J., Jun, K.I., Kim, N.H., et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis 19 (2013), 1892–1894.
3. 3 Takahashi, T., Maeda, K., Suzuki, T., Ishido, A., Shigeoka, T., Tominaga, T., et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis 209 (2014), 816–827.
4. 4 Liu, L., Lu, Q.B., Cui, N., Li, H., Li, Y.W., Liu, K., et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in China who had severe fever with thrombocytopenia syndrome. Clin Infect Dis 57 (2013), 1292–1299.
5. 5 Zhang, Y.Z., He, Y.W., Dai, Y.A., Xiong, Y.W., Zheng, H., Zhou, D.J., et al. Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis 54 (2012), 527–533.
6. 6 Yu, X.J., Liang, M.F., Zhang, S.Y., Liu, Y., Li, J.D., Sun, Y.L., et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 364 (2011), 1523–1532.
7. 7 Bao, C.J., Guo, X.L., Qi, X., Hu, J.L., Zhou, M.H., Varma, J.K., et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis 53 (2011), 1208–1214.
8. 8 Tang, X., Wu, W., Wang, H., Du, Y., Liu, L., Kang, K., et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis 207 (2013), 736–739.
9. 9 Ding, S., Niu, G., Xu, X., Li, J.P., Zhang, X.M., Yin, H.Y., et al. Age is a critical risk factor for severe fever with thrombocytopenia syndrome. PLoS One, 9, 2014, e111736.
10. 10 Sun, Y., Jin, C., Zhan, F., Wang, X., Liang, M., Zhang, Q., et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J Infect Dis 206 (2012), 1085–1094.
11. 11 Lu, Q.B., Cui, N., Hu, J.G., Chen, W.W., Xu, W., Li, H., et al. Characterization of immunological responses in patients with severe fever with thrombocytopenia syndrome: a cohort study in China. Vaccine 33 (2015), 1250–1255.
12. 12 Deng, B., Zhou, B., Zhang, S., Zhu, Y., Han, L., Geng, Y., et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome bunyavirus infection in Northeast China. PLoS One, 8, 2013, e80802.
13. 13 Lubaki, N.M., Ilinykh, P., Pietzsch, C., Tigabu, B., Freiberg, A.N., Koup, R.A., et al. The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains. J Virol 87 (2013), 7471–7485.
14. 14 Liu, W.C., Lin, Y.L., Spearman, M., Cheng, P.Y., Butler, M., Wu, S.C., Influenza virus hemagglutinin glycoproteins with different N-glycan patterns activate dendritic cells in vitro. J Virol 90 (2016), 6085–6096.
15. 15 Stone, A.E., Giugliano, S., Schnell, G., Cheng, L., Leahy, K.F., Golden-Mason, L., et al. Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of lambda-interferons by human plasmacytoid dendritic cells. PLoS Pathog, 9, 2013, e1003316.
16. 16 Rodriguez-Madoz, J.R., Bernal-Rubio, D., Kaminski, D., Boyd, K., Fernandez-Sesma, A., Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84 (2014), 4845–4850.
17. 17 Martins Sde, T., Silveira, G.F., Alves, L.R., Duarte dos Santos, C.N., Bordignon, J., Dendritic cell apoptosis and the pathogenesis of dengue. Viruses 4 (2012), 2736–2753.
18. 18 Zheng, Z., Zou, Z.S., Fu, J.L., Cai, L., Jin, L., Liu, Y.J., Wang, F.S., Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure. J Hepatol 49 (2008), 396–406.
19. 19 Liu, Q., He, B., Huang, S.Y., Wei, F., Zhu, X.Q., Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis 14 (2014), 763–772.
20. 20 Ding, F., Zhang, W., Wang, L., Hu, W., Soares Magalhaes, R.J., Sun, H., et al. Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011–2012. Clin Infect Dis 56 (2013), 1682–1683.
21. 21 Deng, B., Zhang, S., Geng, Y., Zhang, Y., Wang, Y., Yao, W., et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One, 7, 2012, e41365.
22. 22 Sun, L., Hu, Y., Niyonsaba, A., Tong, Q., Lu, L., Li, H., et al. Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med 14 (2014), 389–395, 10.1007/s10238-013-0259-0.
23. 23 Cockburn, I.A., Zavala, F., Dendritic cell function and antigen presentation in malaria. Curr Opin Immunol 40 (2016), 1–6.
24. 24 Cui, N., Bao, X.L., Yang, Z.D., Lu, Q.B., Hu, C.Y., Wang, L.Y., et al. Clinical progression and predictors of death in patients with severe fever with thrombocytopenia syndrome in China. J Clin Virol 59 (2014), 12–17.
25. 25 Gai, Z.T., Zhang, Y., Liang, M.F., Jin, C., Zhang, S., Zhu, C.B., et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis 206 (2012), 1095–1102.
26. 26 Yang, Z.D., Hu, J.G., Lu, Q.B., Guo, C.T., Cui, N., Peng, W., et al. The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome. J Clin Virol 78 (2016), 123–128.
27. 27 Peng, C., Wang, H., Zhang, W., Zheng, X., Tong, Q., Jie, S., et al. Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis 43 (2016), 37–42.
28. 28 De Carvalho Bittencourt, M., Martial, J., Cabié, A., Thomas, L., Césaire, R., Decreased peripheral dendritic cell numbers in dengue virus infection. J Clin Immunol 32 (2012), 161–172.
29. 29 Chang, W.L., Baumgarth, N., Eberhardt, M.K., Lee, C.Y., Baron, C.A., Gregg, J.P., et al. Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. J Immunol 178 (2007), 7794–7804.
30. 30 Pulendran, B., Tang, H., Manicassamy, S., Programming dendritic cells to induce TH2 and tolerogenic responses. Nat Immunol 11 (2010), 647–655.
31. 31 Rodriguez-Madoz, J.R., Belicha-Villanueva, A., Bernal-Rubio, D., Ashour, J., Ayllon, J., Fernandez-Sesma, A., Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84 (2010), 9760–9774.
32. 32 Mesman, A.W., Zijlstra-Willems, E.M., Kaptein, T.M., de Swart, R.L., Davis, M.E., Ludlow, M., et al. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 16 (2014), 31–42.
33. 33 Kushwah, R., Hu, J., Complexity of dendritic cell subsets and their function in the host immune system. Immunology 133 (2011), 409–419.